Inventor
MAERTENS GEERT
BE45 patents
⚠️ This page may combine multiple inventors who share the name “MAERTENS GEERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNOGENETICS NV
36 patentsUS6548244B2Apr 15, 2003
Process for typing HCV isolates
INNOGENETICS NV33 citations96
US5846704ADec 8, 1998
Process for typing of HCV isolates
INNOGENETICS NV59 citations96
US6150134ANov 21, 2000
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV43 citations95
US7122306B2Oct 17, 2006
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS NV17 citations92
US7101561B2Sep 5, 2006
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV21 citations92
US6974864B2Dec 13, 2005
Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
INNOGENETICS NV19 citations92
US6890737B1May 10, 2005
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV15 citations92
US6709812B1Mar 23, 2004
Method for typing and detecting HBV
INNOGENETICS NV22 citations92
US6495670B1Dec 17, 2002
Process for typing of HCV isolates
INNOGENETICS NV17 citations92
US6051696AApr 18, 2000
Process for typing of HCV isolates
INNOGENETICS NV18 citations92
US6689368B1Feb 10, 2004
Immunodominant human T-cell epitopes of hepatitis C virus
INNOGENETICS NV15 citations90
US6635257B1Oct 21, 2003
Particles of HCV envelope proteins: use for vaccination
INNOGENETICS NV28 citations90
US6613333B1Sep 2, 2003
Immunodominant human T-cell epitopes of hepatitis C virus
INNOGENETICS NV29 citations90
US6171784B1Jan 9, 2001
Process for typing of HCV isolates
INNOGENETICS NV14 citations82
US5910404AJun 8, 1999
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV13 citations80
US7313357B2Dec 25, 2007
Method for typing and detecting HBV
INNOGENETICS NV7 citations74
US6521403B1Feb 18, 2003
Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
INNOGENETICS NV7 citations74
US6245503B1Jun 12, 2001
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV11 citations73
US6576417B2Jun 10, 2003
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV8 citations71
US6287761B1Sep 11, 2001
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV8 citations71
US6007982ADec 28, 1999
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV15 citations71
US5922532AJul 13, 1999
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV6 citations71
US7855052B2Dec 21, 2010
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS NV2 citations63
US7258977B1Aug 21, 2007
Process for typing of HCV isolates
INNOGENETICS NV3 citations63
US7195765B2Mar 27, 2007
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS NV2 citations63
US7129337B1Oct 31, 2006
Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
INNOGENETICS NV2 citations63
US6891026B2May 10, 2005
Process for typing of HCV isolates
INNOGENETICS NV1 citations63
US6855318B1Feb 15, 2005
Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
INNOGENETICS NV3 citations63
US6670114B1Dec 30, 2003
Host derived proteins binding HCV: medical, diagnostic and purification use
INNOGENETICS NV4 citations63
US7026457B2Apr 11, 2006
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV2 citations62
US6872520B2Mar 29, 2005
Synthetic antigens for the detection of antibodies to hepatitis C virus
INNOGENETICS NV2 citations60
US7255997B1Aug 14, 2007
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS NV0 citations52
US7108855B2Sep 19, 2006
Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
INNOGENETICS NV0 citations52
US6887985B2May 3, 2005
Process for typing of HCV isolates
INNOGENETICS NV0 citations52
US6841353B2Jan 11, 2005
Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
INNOGENETICS NV1 citations52
US7935490B2May 3, 2011
Immunodiagnostic assays using reducing agents
INNOGENETICS NV1 citations50
INNOGENETICS SA
3 patentsUS6762024B2Jul 13, 2004
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS SA32 citations92
US7157226B1Jan 2, 2007
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
INNOGENETICS SA4 citations73
US7258982B2Aug 21, 2007
Process for typing of HCV isolates
INNOGENETICS SA2 citations62